Rheumatoid arthritis (RA) is a chronic autoimmune condition that causes inflamed joints with pain, swelling, stiffness, and reduced range of motion. It most often affects women. Symptoms may come and ...

Methotrexate belongs to a class of drugs called antimetabolites. This type of drug slows the growth of skin cells or cancer cells and suppresses the immune system. In addition to treating rheumatoid ...

Vienna, Austria - Patients with rheumatoid arthritis (RA) who had inadequate response to a first course of methotrexate but have not had major toxicity may be good candidates for a second round of ...

Methotrexate is one of the oldest and most cost-effective medicines available for rheumatoid arthritis (RA). Its also one of the most commonly used RA therapies. Heres what to know about this drug if ...

SetPoint Medical, a company dedicated to developing therapies for people living with chronic autoimmune diseases, today ...

CHICAGO — Supplementation with fiber to stimulate short-chain fatty acid (SCFA) production in patients with rheumatoid arthritis (RA), or direct supplementation with the SCFA butyrate, appears to ...

The study analyzed 20 clinical prediction models (CPMs) for rheumatoid arthritis (RA), all of which were deemed to have a high risk of bias, leading the researchers to urge against their use to guide ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

The American College of Rheumatology (ACR) has issued new guidelines on the treatment of rheumatoid arthritis, addressing questions about initial treatment with methotrexate and minimizing reliance on ...

AbolerIS Pharma ("AbolerIS"), a clinical-stage biopharmaceutical company committed to improving the lives of people suffering from autoimmune and inflammatory diseases, announced today that the first ...

Patients with rheumatoid arthritis (RA) who receive immune checkpoint inhibitor (ICI) therapy for cancer do not appear to face higher mortality compared against patients without RA receiving the same ...